Filing Details
- Accession Number:
- 0001144204-16-075186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-11 17:57:01
- Reporting Period:
- 2016-01-11
- Filing Date:
- 2016-01-11
- Accepted Time:
- 2016-01-11 17:57:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
910267 | Titan Pharmaceuticals Inc | TTNP.OB | Biological Products, (No Disgnostic Substances) (2836) | 943171940 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1180755 | Sunil Bhonsle | 400 Oyster Point Blvd., Suite 505 So. San Francisco CA 94080 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-01-11 | 17,000 | $3.18 | 107,974 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 54,684 | Indirect | By Family Trust |
Footnotes
- Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $3.00 to $3.40. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- The reporting person serves as trustee of the family trust.